CD38 enzyme blockade (TeneoBio)

N/A

Report date: 2025/03/19 11:37:05

Base Information

Drug NameCD38 enzyme blockade (TeneoBio)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody

Mechanisms of ActionLymphocyte differentiation antigen CD38 inhibitors

TargetsLymphocyte differentiation antigen CD38

Therapy Area/IndicationsMetabolic Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTeneobio Inc

China Registration ClassN/A

Active CompaniesTeneobio Inc

Inactive CompaniesN/A

Active IndicationsMetabolic Diseases

Inactive IndicationsN/A

ATC CodeN/A